
PF-06273340
CAS No. 1402438-74-7
PF-06273340( PF06273340 | PF6273340 )
Catalog No. M11678 CAS No. 1402438-74-7
PF-06273340 is a potent and selective, orally bioavailable pan-Trk kinase inhibitor with IC50 of 6, 2, and 1 nM for Trk A, B and C, respectively.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 133 | Get Quote |
![]() ![]() |
5MG | 179 | Get Quote |
![]() ![]() |
10MG | 430 | Get Quote |
![]() ![]() |
100MG | Get Quote | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NamePF-06273340
-
NoteResearch use only, not for human use.
-
Brief DescriptionPF-06273340 is a potent and selective, orally bioavailable pan-Trk kinase inhibitor with IC50 of 6, 2, and 1 nM for Trk A, B and C, respectively.
-
DescriptionPF-06273340 is a potent and selective, orally bioavailable pan-Trk kinase inhibitor with IC50 of 6, 2, and 1 nM for Trk A, B and C, respectively; displays selectivity over a panel of ion channels, receptors and other enzymes; exhibits in vivo efficacy in a rodent model of inflammatory pain.Pain Phase 1 Discontinued.
-
In Vitro——
-
In Vivo——
-
SynonymsPF06273340 | PF6273340
-
PathwayTyrosine Kinase
-
TargetTrk Receptor
-
RecptorTrk Receptor
-
Research AreaNeurological Disease
-
IndicationPain
Chemical Information
-
CAS Number1402438-74-7
-
Formula Weight479.93
-
Molecular FormulaC23H22ClN7O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESNC1=NC=C2C(N(C(C)(C)CO)C=C2C(C3=CN=CC(NC(CC4=CC=C(Cl)C=N4)=O)=C3)=O)=N1
-
Chemical NameN-(5-(2-amino-7-(1-hydroxy-2-methylpropan-2-yl)-7H-pyrrolo[2,3-d]pyrimidine-5-carbonyl)pyridin-3-yl)-2-(5-chloropyridin-2-yl)acetamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Skerratt SE, et al. J Med Chem. 2016 Nov 23;59(22):10084-10099.
molnova catalog



related products
-
CH7057288
CH7057288 is an effective and selective TRK inhibitor with an IC50 value of 1.1 nM 7.8 nM and 5.1 nM for TRKA TRKB and TRKC respectively.
-
LOXO-101 sulfate
LOXO-101 (ARRY-470, Larotrectinib) is potent, selective pan-TRK inhibitor with cellular IC50 of 2-20 nM against TRKA, TRKB, and TRKC kinases.
-
LM11A-31 dihydrochlo...
An orally available, brain penetrant p75NTR ligand that blocks p75-mediated cell death, also increases proliferation and survival of hippocampal neural progenitors.